Medical Conference Schedule Sept. 2013 through March 2014

Medical Co.'s New Joint Venture Could Expand Co.'s Footprint
Source: Dr. Douglas Loe (08/13/2025)

Leede Financial Inc. analyst Dr. Douglas Loe gave this company a Buy rating.

read more >

Canadian Pharmaceutical Company Discovers Breakthrough Cardiovascular Treatment
Source: Streetwise Reports (08/11/2025)

Clinical-stage life sciences company Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) announces topline results from its Phase II clinical study involving patients with acute myocarditis. Read why analysts like this pharmaceutical stock.

read more >

Biotech Announces Topline Results From Cardiovascular Drug Trial
Source: Brandon Folkes (08/11/2025)

Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) Analyst Brandon Folkes reviews Cardiol Therapeutics Inc. after it announced the topline results from its Phase II ARCHER trial of CardiolRx in acute myocarditis.

read more >

Pharmaceutical Company Discovers Breakthrough Heart Treatment in Canada
Source: Jason Wittes (08/11/2025)

Top-line results from Cardiol Therapeutics' (CRDL:TSX; CRDL:NASDAQ) ARCHER study for Acute Myocarditis are quite promising, writes Roth Capital Partners Analyst Jason Wittes in an updated research note.

read more >

Canadian Pharma Finds Promising Cardiovascular Breakthrough
Source: Douglas Loe (08/08/2025)

Cardiol Therapeutics (CRDL:TSX; CRDL:NASDAQ) reports headline Phase II data from its 109-patient acute myocarditis study, known as the ARCHER trial. Read to see how one analyst rates the stock.

read more >